B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 Recruiting
48 enrolled
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/3 Recruiting
1,122 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
Musculoskeletal Cancers Remote Monitoring and Care
Phase NA Recruiting
60 enrolled
LUPARPED
Phase 1/2 Recruiting
25 enrolled
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 Recruiting
90 enrolled
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Phase 2 Recruiting
40 enrolled
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/2 Recruiting
289 enrolled
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/2 Recruiting
104 enrolled
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Phase 1 Recruiting
18 enrolled
ISG Os2Oss
Recruiting
120 enrolled
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Phase 1 Recruiting
24 enrolled
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2 Recruiting
56 enrolled
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 Recruiting
45 enrolled
UFSR for OS
Recruiting
10 enrolled
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 Recruiting
60 enrolled
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 Recruiting
27 enrolled
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Recruiting
300 enrolled
AflacST2301
Phase 1 Recruiting
12 enrolled
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Phase 1 Recruiting
24 enrolled
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 Recruiting
62 enrolled
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/2 Recruiting
147 enrolled
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Phase 1/2 Recruiting
63 enrolled
REGOSTA
Phase NA Recruiting
168 enrolled
REGOMAIN
Phase 2 Recruiting
36 enrolled
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Phase 1 Recruiting
30 enrolled
Pediatric PET/MR Image Registry
Recruiting
100 enrolled
SPEARHEAD-3 Pediatric Study
Phase 1/2 Recruiting
20 enrolled
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Phase 1/2 Recruiting
55 enrolled
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Phase NA Recruiting
150 enrolled
GISAR
Recruiting
9,000 enrolled
PREMOST
Recruiting
40 enrolled
Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 Recruiting
41 enrolled
ADER
Recruiting
50 enrolled
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Phase 1 Recruiting
25 enrolled